Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of SBIR/STTR awards granted to Molecular Targeting Technologies

where

SBIR/STTR Award Recipient

Molecular Targeting Technologies

Name	Description	SBIR/STTR Award Recipient	Government Branch	Award Type	Contract Number (US Government)	Award Phase	Award Amount (USD)	Date Awarded	Official Website
‌ Molecular Targeting Technologies, Inc. SBIR Phase II Award, September 2022	A SBIR Phase II contract was awarded to Molecular Targeting Technologies in September, 2022 for $999,389.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Molecular Targeting Technologies	National Institutes of Health	SBIR	1R44CA275434-01	Phase II	999,389	September 1, 2022	sbir.gov/node/2340441
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award, April 2018	A SBIR Phase I contract was awarded to Molecular Targeting Technologies in April, 2018 for $253,411.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Molecular Targeting Technologies	National Institutes of Health	SBIR	1R43CA224579-01A1	Phase I	253,411	April 9, 2018	sbir.gov/node/1574165
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $50,007.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Molecular Targeting Technologies	National Institutes of Health	SBIR	261201700037C-3-0-0	Phase I	50,007		sbir.gov/node/1465077
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award, August 2017	A SBIR Phase I contract was awarded to Molecular Targeting Technologies in August, 2017 for $214,174.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43AI133620-01	Phase I	214,174	August 1, 2017	sbir.gov/node/1322709
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award, April 2015	A SBIR Phase I contract was awarded to Molecular Targeting Technologies in April, 2015 for $224,819.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43HL127892-01	Phase I	224,819	April 1, 2015	sbir.gov/node/1030797
‌ Molecular Targeting Technologies, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to Molecular Targeting Technologies for $162,433.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		STTR	1R41AI081334-01A1	Phase I	162,433		sbir.gov/content/human-rabies-virus-vaccine-development-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $222,581.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	N43HB140043	Phase I	222,581		sbir.gov/node/709725
‌ Molecular Targeting Technologies, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to Molecular Targeting Technologies for $1,067,665.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		STTR	1R41AI063822-01A2	Phase I	1,067,665		sbir.gov/content/novel-rhabdovirus-based-anthrax-vaccine-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Molecular Targeting Technologies for $700,000.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	2R44CI000081-02	Phase II	700,000		sbir.gov/content/potent-rabies-vaccines-free-ranging-carnivores-2
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $808,065.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R44CA136306-01	Phase I	808,065		sbir.gov/content/radiohybridization-imaging-her2-oncogene-detect-breast-cancer-0
‌ Molecular Targeting Technologies, Inc. STTR Phase I Award,	A STTR Phase I contract was awarded to Molecular Targeting Technologies for $669,400.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		STTR	1R41AI073064-01A1	Phase I	669,400		sbir.gov/content/novel-vaccine-botulinum-neurotoxin-subunit-viral-carrier-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $224,438.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43AI094709-01A1	Phase I	224,438		sbir.gov/node/399620
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $100,000.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43CI000081-01	Phase I	100,000		sbir.gov/content/potent-rabies-vaccines-free-ranging-carnivores-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $176,838.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43EB009266-01	Phase I	176,838		sbir.gov/content/superior-near-ir-dyes-bioimaging-0
‌ Molecular Targeting Technologies, Inc. STTR Phase II Award,	A STTR Phase II contract was awarded to Molecular Targeting Technologies for $836,316.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		STTR	2R42AI081334-02	Phase II	836,316		sbir.gov/content/human-rabies-virus-vaccine-development-1
‌ Molecular Targeting Technologies, Inc. STTR Phase II Award,	A STTR Phase II contract was awarded to Molecular Targeting Technologies for $2,509,160.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		STTR	2R42AI073064-03A1	Phase II	2,509,160		sbir.gov/node/391358
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $193,511.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43EB009591-01	Phase I	193,511		sbir.gov/content/bright-and-stable-near-ir-dyes-bioimaging-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $219,935.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43GM108470-01	Phase I	219,935		sbir.gov/node/678068
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $196,224.0 USD from the U.S. Department of Health & Human Services.	Molecular Targeting Technologies		SBIR	1R43GM093417-01	Phase I	196,224		sbir.gov/node/7545
‌ Molecular Targeting Technologies, Inc. SBIR Phase I Award,	A SBIR Phase I contract was awarded to Molecular Targeting Technologies for $79,700.0 USD from the U.S. Department of Agriculture.	Molecular Targeting Technologies		SBIR	2006-33610-16801	Phase I	79,700		sbir.gov/content/selection-and-testing-recombinant-cav-2-rabies-vaccine-oral-immunization-wildlife-0
‌ Molecular Targeting Technologies, Inc. SBIR Phase II Award,	A SBIR Phase II contract was awarded to Molecular Targeting Technologies for $346,000.0 USD from the U.S. Department of Agriculture.	Molecular Targeting Technologies		SBIR	2007-33610-18486	Phase II	346,000		sbir.gov/content/selection-and-testing-recombinant-cav-2-rabies-vaccine-oral-immunization-wildlife-2
‌ MOLECULAR TARGETING TECHNOLOGIES, INC. STTR Phase I Award, February 2023	A STTR Phase I contract was awarded to Molecular Targeting Technologies in February, 2023 for $299,890.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health.	Molecular Targeting Technologies	National Institutes of Health	STTR	1R41HL167303-01	Phase I	299,890	February 1, 2023	sbir.gov/node/2502687

22 results

0 selected

22 results

0 selected